Dipna Pharmachem

20.00
+0.95
(4.99%)
Market Cap
48.08 Cr
EPS
0.90
PE Ratio
42.33
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
19.05
52 Week Low
6.40
PB Ratio
1.22
Debt to Equity
0.57
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,787.40
#1 4,28,857.13
36.71
#1 49,887.20
12.06
#1 9,648
13.77
59.27
6,012.50
1,59,612.98
79.83
8,184.00
0.89
1,600
#1 64.53
57.99
1,525.90
1,23,233.96
25.11
26,520.70
14.17
4,155
47.38
57.43
3,238.90
1,09,619.09
60.42
10,785.70
11.59
1,656
13.54
52.37
2,557.50
1,05,516.96
52.60
10,615.60
19.57
1,942
-16.38
59.98
1,174.80
98,031.82
#1 18.66
28,905.40
12.36
5,578
1.69
54.12
2,019.60
92,203.01
33.50
20,141.50
#1 19.94
1,936
38.82
50.28
859.65
86,500.90
19.53
19,831.50
13.82
3,831
29.92
46.44
1,220.10
70,863.61
20.72
29,559.20
17.55
3,169
-10.04
58.85
29,705.00
63,121.05
47.82
6,097.20
10.80
1,201
16.01
45.94
Growth Rate
Revenue Growth
64.46 %
Net Income Growth
22.22 %
Cash Flow Change
74.17 %
ROE
-22.73 %
ROCE
3.02 %
EBITDA Margin (Avg.)
-11.06 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
17
20
31
31
73
100
164
0
Expenses
17
20
31
31
71
98
161
0
EBITDA
0
0
0
0
2
2
3
0
Operating Profit %
0 %
0 %
0 %
1 %
3 %
2 %
2 %
0 %
Depreciation
0
0
0
0
0
0
0
0
Interest
0
0
0
0
1
1
2
0
Profit Before Tax
0
0
0
0
2
1
1
0
Tax
0
0
0
0
0
1
0
0
Net Profit
0
0
0
0
1
1
1
0
EPS in ₹
17.27
9.15
16.86
6.91
333.39
0.76
0.90
0.00

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
11
14
18
25
36
78
133
Fixed Assets
0
0
0
0
0
0
0
Current Assets
11
14
18
25
36
78
133
Capital Work in Progress
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
Other Assets
11
14
18
25
36
78
133
Total Liabilities
11
14
18
25
36
78
133
Current Liabilities
11
14
18
21
29
42
83
Non Current Liabilities
0
0
0
4
6
11
13
Total Equity
1
1
1
1
2
24
38
Reserve & Surplus
0
1
1
1
2
12
14
Share Capital
0
0
0
0
0
12
24

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
6
8
Investing Activities
0
0
0
0
0
Operating Activities
-3
-2
3
-21
-5
Financing Activities
3
3
-3
27
14

Share Holding

% Holding
Jul 2022
Sept 2022
Mar 2023
Sept 2023
Dec 2023
Mar 2024
Sept 2024
Promoter
100.00 %
66.56 %
66.56 %
57.19 %
9.98 %
9.98 %
9.98 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
31.32 %
31.36 %
40.33 %
63.07 %
63.07 %
81.82 %
Others
0.00 %
2.12 %
2.08 %
2.48 %
26.95 %
26.95 %
8.20 %
No of Share Holders
7
1,178
992
1,078
1,807
1,807
2,652

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Submission Of Voting Results Of Extra Ordinary General Meeting Of The Company Under Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 07, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 07, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMApr 04, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMApr 04, 2025
Closure of Trading WindowMar 29, 2025
Notice Of Extra-Ordinary General Meeting (EGM) Of The CompanyMar 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Wednesday 12Th March 2025Mar 12, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 07, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Monday 24Th February 2025Feb 24, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 11, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday 6Th February 2025Feb 06, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Clarification Sought On Significant Movement In PriceDec 30, 2024
Clarification sought from Dipna Pharmachem LtdDec 30, 2024
Results-Delay in Financial ResultsDec 18, 2024
Results-Delay in Financial ResultsDec 11, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 11Th December, 2024Dec 11, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerNov 27, 2024
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Nov 13, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Submission Of Outcome Of Board Meeting And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Oct 11, 2024
Board Meeting Outcome for Submission Of Outcome Of Board Meeting And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Oct 11, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 18Th September, 2024Sep 18, 2024
Submission Of Voting Results Of Annual General Meeting Of The Company Under Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Aug 29, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 29, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 27, 2024
Intimation Of Book Closure Pursuant To Regulation 42 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015Aug 06, 2024
Reg. 34 (1) Annual Report.Aug 05, 2024
Submission Of Annual Report For Financial Year 2023-24Aug 05, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 29Th July, 2024Jul 29, 2024
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Jul 24, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 17, 2024
Submission Of Audited Financial Results For The Half Year And Year Ended On 31St March, 2024 Along With Auditor'S ReportJun 12, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 12Th June, 2024Jun 12, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, 12Th June, 2024Jun 10, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May, 2024May 06, 2024
Board Meeting Intimation for Re-Schedule Of Board Meeting Held Today I.E. 2Nd May, 2024May 02, 2024
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015May 01, 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024Apr 27, 2024
Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024Apr 26, 2024
Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 26Th April, 2024 To 2Nd May, 2024Apr 25, 2024
Update on board meetingApr 22, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Apr 18, 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Apr 18, 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Apr 18, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Apr 18, 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Apr 18, 2024

Technical Indicators

RSI(14)
Neutral
73.27
ATR(14)
Volatile
1.03
STOCH(9,6)
Overbought
84.83
STOCH RSI(14)
Neutral
78.55
MACD(12,26)
Bullish
0.30
ADX(14)
Strong Trend
39.39
UO(9)
Bearish
55.97
ROC(12)
Uptrend But Slowing Down
27.00
WillR(14)
Overbought
-16.13